Cooper Norcross Health clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
3 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 0 with minor changes only.
- Notable: Duration of Immobilization After Reverse Total Arthroplasty for Proximal Humerus Fractures Primary completion pushed from Feb 1, 2026 to Feb 1, 2027
- Notable: Liposomal Bupivacaine Nerve Block (Exparel) in Rotator Cuff Surgery Sponsor changed: The Cooper Health System to Cooper Norcross Health
- Notable: Total Shoulder Arthroplasty Preoperative Pain Threshold and Association With Postoperative Opioid Consumption Sponsor changed: The Cooper Health System to Cooper Norcross Health
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1/2 | 1 | |
| Phase 2 | 1 | |
| Phase 3 | 1 | |
| Phase 4 | 3 |
Not charted: 10 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Lung Cancer (2) · Anxiety (1) · Breast Cancer (1) · Glioblastoma (1) · Glioma (1) · Heart Disease (1) · Heart Failure (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Stroke (1)
Get alerts when Cooper Norcross Health's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.